Derived from our results, BigDyn may act as an attenuator of cell toxicity and amyloid aggregation, becoming a potential peptidic therapy in AD, by stabilizing Aβ40 aggregation in a less toxic or neuroprotective state. The gene discussed is PDYN; the disease is Alzheimer disease.